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• Study aimed to identify specialized bleeding/thrombosis nurses’ needs to inform 
future education 
• Mixed-methods approach combined qualitative and quantitative data collected in 
nine countries 
• Areas of need identified: von Willebrand disease, individualizing care, thrombosis 
assessments 
• Poor access to relevant education reported as a main barrier to nurses’ 
professional development 
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Thrombosis assessments, von Willebrand disease, and adapting care to individual patient needs have 
been identified as priorities to support nurses working in thrombosis and haemostasis in their 
continuing education efforts.  
 
 
According to a new international mixed-method study, thrombosis assessments, von Willebrand 
disease, and guidance on individualizing care should be continuing education priorities for nurses 
specialized in bleeding & clotting disorders. 
 
 
 
 
The need for a more integrated, multi-disciplinary approach to care for individuals with 
bleeding or clotting disorders has been highlighted in recent years. Evidence-based 
education adapted to nurses’ needs is essential for a successful evolution.  However, limited 
data currently exist on the clinical challenges nurses face in this specialty area.  
 
Identify barriers and challenges faced by specialty nurses, and determine possible causes, to 
develop appropriate educational interventions. 
 
A mixed-methods study, combining qualitative (semi-structured interviews) and 
quantitative (online survey) data was conducted on the challenges experienced by 
haemostasis nurses in nine countries (Argentina, Australia, Canada, China, France, Germany, 
Spain, the UK, and the US), and deployed in five languages (English, French, German, 
Mandarin and Spanish).  Qualitative data were analyzed using thematic analysis. 
Quantitative data were analyzed using frequency tables, chi-squares and standard 
deviations. 
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Participants (n=234) included nurses (n=212; n=22 qualitative; n=190 quantitative); and 
patients receiving care for bleeding or clotting conditions or their caretakers (n=22 
qualitative phase only). Through triangulated data analysis, six challenging areas emerged: 
1) Understanding of von Willebrand disease (VWD); 2) Anticoagulant safety profile in 
specific patients; 3) Understanding the treatment of patients with inhibitors; 4) Patient risk 
assessments; 5) Individualization of care and communication with patients; 6) Accessing and 
implementing relevant professional education. 
 
This needs assessment provides a comprehensive illustration of the current challenges faced 
by nurses in the field of bleeding and clotting disorders, and indicates where gaps in skills, 
knowledge or confidence would benefit from nurse-specific educational programming.  
 
 
 
Nursing care;  
Health Knowledge, Attitudes, Practice 
Clinical competence;  
Nurse-Patient relations;  
von Willebrand Disease; 
Blood Coagulation Disorders 
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Coagulation disorders include many chronic conditions that require life-long treatments to 
reduce risk of hemorrhage (bleeding disorders) or of blood clotting. A multidisciplinary, 
approach to patients with bleeding and clotting disorders has been shown to improve 
clinical outcomes, decrease mortality rates, and improve cost-effectiveness in health care 
settings
1-3
. Nurses play a crucial role as part of the multidisciplinary team providing care to 
these patients.  Nursing responsibilities include providing direct clinical care, patient and 
family support, providing clear patient education on their condition, administering 
treatment, providing assistance during lifestyle adjustments, monitoring for early signs of 
complications, taking patient history, and in many settings, participating in treatment 
decisions with the team
4-6
.  
Multiple challenges related to providing care to patients with bleeding or thrombotic 
disorders were identified in the literature. For example, it has been reported the diagnostic 
process for von Willebrand disease (VWD) is complex, and testing and assessment is 
challenging
7-9
, due to the variety of patient profiles and multiple types and sub-types of the 
disease. These challenges to VWD diagnosis are further complicated by a lack of 
standardized diagnostic tools, especially in pediatric settings
10
.  
In another example, the use of direct oral anticoagulants (DOACs) for patients with 
thrombotic disorders poses a challenge, as it requires nurses and others on the healthcare 
team to adapt patient monitoring practices in order to reduce risk of adverse events and 
side-effects
11
. Observational data also suggest nurses’ lack of understanding of the 
appropriate dosage of pharmacological agents in patients with thrombotic disorders, was 
combined with misunderstanding of the necessity of those treatments
12
. 
As part of a team of health care providers (HCPs), nurses may experience unique challenges 
when caring for patients with coagulation disorders. However, limited research is available 
that describes the nursing perspective in this field.  
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This study aims to identify the areas where nurses experienced challenges when educating, 
treating, and communicating with patients with a coagulation disorder; and to identify the 
causes of these challenges (e.g. lack of knowledge or skills). Study findings can be applied to 
the future development of targeted, relevant educational programs for nurses.  
 
 
 
A mixed-methods approach was used to assess the educational needs of nurses, combining 
an exploratory qualitative phase consisting of semi-structured interviews with nurses and 
patients / caregivers, which led to, and informed a quantitative validation phase with nurses 
only.  A mixed-methods approach allows for triangulation of data collection methods 
(qualitative and quantitative) and sources (nurses and patients / caregivers) to gain a 
trustworthy and in-depth understanding of a problematic issue
13,14
, in this case, the 
challenges experienced by nurses.   
 
 
To be eligible, participants must practice in one of nine countries (Argentina, Australia, 
Canada, China, France, Germany, Spain, the United Kingdom (UK), or the United States 
(US)), and be employed as a nurse, nurse practitioner, or registered nurse (or the local 
equivalent of that designation). They must have at least one year of work experience, with 
at least 50% of their professional time working in the field of thrombosis and haemostasis. 
In Australia, those who spent 20% or more of their time in thrombosis and haemostasis 
were deemed eligible for this study, to reach the sample quota for this country. 
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Nurses were recruited from the selected countries using a purposive sampling method
15
 
that included participants with different levels of practice experience, and various practice 
settings (i.e. academic, community). Nurses were contacted via the International Society on 
Thrombosis and Haemostasis (ISTH) database, from within the networks of AXDEV Group, 
and through the Global Hemostasis Nurses Alliance (GHNA). The countries included in this 
study were selected to represent a range of patient and nurse experiences, and to reflect 
the membership distribution of ISTH, WFH (World Federation of Hemophilia) and GHNA 
nurses, which all represent nurses and the field of thrombosis and haemostasis.   
Increasing evidence supports patient involvement in the early phases of the design of 
evidence-based medical education
16,17
.  The inclusion of patients/caregivers in this study 
recognizes these experiences as valuable sources for data triangulation, which is used to 
corroborate or broaden the nurses’ voiced challenges. Eligible patients/caregivers must live 
in one of the nine targeted countries, and have a thrombotic or bleeding condition for which 
they or their child received nursing care in the past five years. This timeframe was chosen so 
they would have sufficient recall of the nursing care they had received. Patients/caregivers 
were not included in the quantitative phase of this study, as their input was used primarily 
to contextualize the nurses’ narratives, and to understand differences in perspective.  
 
International ethics approval was granted by two independent ethical review boards (IRB): 
one for the main study protocol that involved nurses (VERITAS, QC, Canada) and one for the 
complementary protocol that included patients and caregivers (Chesapeake IRB, Columbia, 
MD, US). An informed consent agreement was read and approved by each participant 
before their interview or survey. Participants received financial compensation for their 
participation, in accordance with ethical regulations.  
 
 
Participants completed a 45-minute semi-structured interview. The interview guide was 
designed by educational experts (co-authors PL, SL, SM) based on a review of the existing 
Au
th
or
 M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved 
literature regarding nurses' roles in the care of patients with coagulation disorders. 
Interview guide topics were discussed with clinical experts (co-authors JM, RB, KK, AL, MM, 
TR, FN) prior to finalizing the interview guide. The interview guide was comprised of open-
ended questions designed to elicit unbiased and in-depth responses. Interviews were 
conducted in the participants' local language (English, French, German, Mandarin, and 
Spanish) and recorded with the participant’s consent. Interviews were transcribed and 
translated to English.  
Patient/caregiver interview questions were designed to be applicable if participants were 
responding on behalf of themselves or their child. Interviews avoided the use of technical 
language or jargon to focus on the patient experiences
18
. 
All interviewers participated in a debrief session to outline emerging themes, and construct 
the coding “tree” for the directed content analysis
19
. Interview transcripts were coded using 
N-Vivo 7.0 software (QSR International, Cambridge, MA). In cases where data from the 
transcript did not fit into the framework, new codes were developed, and integrated 
thematically into the coding “tree”. Interviews were transcribed and coded until data 
saturation was reached- when no new codes emerged from the interviews
20
. Emerging 
themes were contextualized and interpreted by clinical experts and educational experts (co-
authors PL, SL, SM, TR). Key findings were used to construct an online quantitative survey.  
 
Quantitative data were collected via a 20-minute online survey, designed based on the 
emerging themes of the qualitative phase, and with the intent of validating the reported 
challenges with a larger sample. Nurses were asked to use a 5-point scale to rate their own 
level of knowledge, skills, confidence and support, according to the level expected in their 
professional role. Nurses also indicated their level of agreement with certain statements, 
the frequency in which they perform particular tasks (and the perceived level of difficulty of 
those tasks), and to select barriers that most negatively impacted patient care (see 
Supplementary material 1).  
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Analysis of survey data using SPSS software (IBM SPSS 22.0 software, IBM Corporation, 
Armonk, NY) included frequencies and cross-tabulations. In order to identify differences 
between sub-groups (country; years of practice (YOP) - either 10 YOP and under, or 11 and 
over), Pearson chi-squares were calculated.  
 
The educational researchers used data triangulation
21
 to integrate interview and survey 
data, which enabled them to identify the causes of reported challenges, contextual barriers 
and professional needs
15
. These findings were contextualized by the steering committee, 
based on their clinical expertise. 
 
 
A total of 234 participants were included in this study (Table 1; 212 nurses and 22 patients / 
caregivers). Forty-four interviews were conducted (phase 1, 22 nurses and 22 patients / 
caregivers) and 190 different nurses completed the online survey (phase 2).  
The triangulation of data led to the identification of six main findings related to challenges 
nurses in the field of haemostasis and thrombosis face. These challenges include: 1) the 
understanding of VWD; 2) anticoagulant safety in specific patient profiles; 3) understanding 
the treatment of haemophilia patients with inhibitors; 4) patient risk assessments; 5) 
individualization of care and communication with patients and families; 6) accessing and 
implementing relevant professional education. 
1-   
Several aspects of clinical practice regarding patients with VWD were reported as sub-
optimal by nurses. Sub-optimal knowledge of “which elements of patient and family history 
to collect to inform a potential diagnosis of VWD” was reported by 43% of participants 
(Table  3). Over half of nurses (54%) also reported sub-optimal knowledge, given their 
professional role, of the “criteria to identify the type of VWD”. Furthermore, 50% reported 
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sub-optimal knowledge of the criteria to determine “if the results of basic laboratory tests 
are consistent with VWD, and if so, which type”. Finally, after a diagnosis is confirmed, half 
of nurses (52%) reported sub-optimal knowledge of the “safety profile of treatments for 
VWD”. 
Along with a limited understanding of VWD, were the challenges posed by changing 
diagnostic criteria and fluctuations in individual patient levels observed in VWD diagnostic 
laboratory tests. The elusive criteria of VWD is a substantive theme that emerged from 
qualitative data: 
Von Willebrand disease could be challenging to diagnose.  It requires multiple 
visits and multiple tests and sometimes the results aren’t that clear.  […] 
When you look at the new criteria for levels that constitute a current 
acceptable diagnosis, it doesn’t fit with patients that were diagnosed a long 
time ago, so we’re able to say that they don’t really have it. 
-Nurse, US 
2-   
Sub-optimal knowledge of the “safety profile of anticoagulants” was reported by nurses in 
three particular patient profiles: (1) those with a history of bleeding episodes, (2) neonates 
and the elderly, and (3) cancer patients. 
Knowledge of “the safety profile of anticoagulation medication when used by vulnerable 
patients” was reported to be sub-optimal by 40% of participants; while 33% reported a similar 
knowledge gap in relation to caring for patients treated with anticoagulation medication who also  
have a history of bleeding episodes or bleeding disorders (Table 2). Discomfort using 
anticoagulants in vulnerable patients, including in neonates and the elderly, was also 
recounted during interviews: 
Regarding the anticoagulant field, I think the vulnerable population is 
important. Maybe elderly patients who are poorly controlled by other 
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external agents are a challenge. The challenge is the most vulnerable people, 
assisting both the elder and neonates. 
- Nurse, Spain 
“Knowledge of DOAC safety profiles in cancer patients” was reported to be sub-optimal by 
nearly half of participants (48%). The need for more guidance regarding the safety profile of 
anticoagulants in cancer patients was a substantive theme discussed by interview 
participants: 
NICE [National Institute for Health and Care Excellence] guidance says, on cancer-
related thrombosis, that patients should have a minimal of six months of treatment 
[…]. I guess what I would like is some kind of tool for doing that, for helping that 
assessment to go forward at six months, and a little bit more clear guidance on when 
to continue anticoagulation and when to stop anticoagulation. 
- Nurse, UK 
3-   
Triangulated data identified challenges related to haemophilia and inhibitors faced by 
nurses. Half of participants (51%; Table 2) reported sub-optimal knowledge of the “safety 
profiles of bypassing agents”, used to treat patients with inhibitors.  The knowledge gap was 
higher among nurses with ≤10 YOP (62%), as compared to those with >10 YOP (43%, 
p=0.019). Similarly, 54% reported sub-optimal knowledge of “the goals of inhibitor 
treatment and eradication”, with higher representation among nurses with ≤10 YOP (63%), 
as compared to those with >10 YOP (44%, p=0.02). 
Sub-optimal knowledge of “how to recognize potential inhibitor development” (53%), as 
well as “the inhibitor development risks for previously untreated patients” (52%) were 
reported. Both knowledge gaps were higher among nurses with ≤10 YOP (respectively, 68% 
and 65%) as compared to nurses with >10 YOP (42%, p=0.001 and 44%, p=0. 009). Treating 
patients with inhibitors was reported as challenging for nurses and for patients: 
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What is also a very big problem, especially in haemophilia, is that an 
inhibitor develops, and that is in fact a major challenge for the treating 
physician, but also for the person affected, plus their family, because it’s a 
very, very intensive therapy, and you do really need a good compliance, 
and that is in fact quite tough. 
- Nurse, Germany 
4-  
Challenges regarding multiple facets of patient risk assessments for bleeding and 
thrombosis disorders emerged.  For bleeding disorders, 37% of nurse participants reported 
a sub-optimal level of knowledge of “which elements of a patient’s history are essential for 
the identification of an inherited disorder” (Table 2). In addition, nurses reported a sub-
optimal level of knowledge, given their professional role, of the signs and symptoms of late 
and early hemarthroses (39%), menorrhagia (32%) and the criteria to determine 
haemophilia severity (46%). 
Regarding bleeding disorders, 42% of nurses reported sub-optimal knowledge of how to 
identify immune thrombocytopenia (ITP). This proportion was significantly higher among 
nurses with ≤10 YOP as compared to more experienced nurses (54% vs. 34%, p=0.011).  
As shown in Table 3, sub-optimal skills conducting risk assessments in bleeding disorders 
were also reported. Nearly half of nurses (46%) reported sub-optimal skills, when “assessing 
the bleeding risk for patients with inherited bleeding disorders”. Half of nurses (50%) 
reported sub-optimal skills assessing patients with potential hemarthrosis. This lack of skill 
was reported by nurses from Canada (72%) and Argentina (68%) in greater proportions. 
Additionally, nurses with <10 YOP reported a significantly lower skill level when conducting 
assessments for menorrhagia (51% of those with ≤10 YOP vs. 34% >10 YOP, p=0.028), 
epistaxis (40% vs. 26%, p=0.046), and hematuria (44% vs. 27%, p=0.022).  
A majority of nurses (86%) agreed with the general statement: “I gather patient history very 
often”, and this task was not perceived to be difficult:  only 11% of participants agreed that 
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“gathering patient history is difficult”. In addition, 63% of nurses agreed with the statement 
“I use standardized tools to collect patient history” (Figure 1).  
5-
  
Nurses reported challenges when individualizing the way they care for patients. Forty (40%) 
of nurses agreed that “it is difficult to individualize patient care while respecting protocols” 
(Figure 1). Specifically, a majority of participants agreed that it is difficult to personalize care 
provided according to patient age and cognitive level (58%), and to their life-style and 
preferences (55%). 
In addition, 57% of nurses agreed that “it is difficult to determine the exact level of 
information to provide to the patient on their disease”. When asked to “identify the three 
most significant barriers to providing the best care to patients with thrombosis or bleeding 
disorders”, the top barrier selected by respondents was “lack of awareness among the 
general population regarding thrombosis and haemostasis disorders or risk factors” (54%).   
The third most often selected barrier was the “lack of educational materials that I could 
provide to my patients and caregivers” (39%).   
During interviews, patients substantively mentioned the unavailability of adequate 
information on their specific condition, especially in relation to thrombosis disorders:     
I think nurses need to have more knowledge on the condition overall. I 
struggle to find any nurse at all that has a good enough knowledge of my 
condition. I know more than them, when it comes to nurses. When I go to my 
weekly appointment, they learn a lot from me, rather than the other way 
around. 
- Patient (thrombosis disorder), UK 
It would have been nice if the information had been offered upfront and 
visually in a pamphlet. […] The general communication could have been better 
all around. 
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– Caregiver (thrombosis disorder), Australia 
Patients described the need to self-educate using online sources in the absence of other 
options:  
They said something about some type of substance in the blood that creates 
clotting. I did a little bit of research on my own as well. After I found out about 
the diagnosis, I looked up what it meant to try to figure out what I needed to 
expect […] WebMD and looking, Googling thrombosis and seeing what it 
meant. 
– Caregiver (thrombosis disorder), US 
6-  
Nurses perceived a need for broader educational offerings that are relevant to their 
profession (Figure 1).  More than half (58%) of nurses agreed with the statement that 
“generally, the education offerings are not applicable to the daily reality of my practice”, 
while 70% agreed with “I feel there is a lack of training for nurses regarding how to 
communicate properly and to use language that the patient (or caregivers) can understand”, 
and 75% agreed that “there is a lack of training for nurses regarding how to provide 
psychological support to patients (or caregivers)”. 
Nurses reported that providing proper education on treatments is further complicated by 
the intensity of the patient’s experience:  
Families find it very traumatic and they really need a lot of nurturing and 
support and time to develop competency in doing this and it’s not good 
enough to say: ‘We’re going to start giving your child enoxaparin and you 
can go home tomorrow injecting your baby.’ Parents need more time 
than that. 
-Nurse, Australia 
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Nurses face several challenges in their efforts to improve their knowledge of bleeding and 
clotting disorders. Nurses reported low to acceptable confidence (Figure 2) when 
“identifying adequate training and/or professional development resources for nurses in the 
field of thrombosis and haemostasis” (57%), and when ”implementing clinical practice 
changes based on literature I read or training I have received” (61%).  In addition, there is a 
perceived lack of support from senior clinical staff when seeking mentorship (62%), or to 
improve knowledge (51%).        
   
 
This study identified challenges faced by nurses in the field of coagulation disorders, 
highlighted areas where nurses reported having sub-optimal knowledge or skills, and 
uncovered marked differences between participants according to their country of practice 
or level of experience.  
The indicators for region-specific findings, as illustrated in the tables, could be explained by 
variations in the nurses’ educational preparation, in health systems and in practice norms, 
as these were reported as factors influencing their ability to personalize patient care
22
. In 
terms of education, formal requirements differ among countries. Specialty training for a 
particular area of nursing may be optional or mandatory depending on country, degree, and 
practice setting
22
. Other elements may offer insight into these findings,  such as differences 
in the strength and resources provided by the country’s nursing professional society, the 
provision of job training programs after graduation, and the adequate availability of 
continuing medical education programs
23
.  
Nurses with 10 years of practice or less reported higher gaps in skills and knowledge when 
conducting patient assessments for menorrhagia, haematuria and epistaxis, as well as when 
treating patients with inhibitors, as compared to more experienced nurses. This suggests 
that less experienced nurses entering the field of coagulation disorders would particularly 
benefit from specific educational interventions designed to improve patient assessment and 
the management of challenging patient profiles. These types of educational interventions 
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could take the form of peer-to-peer training between nurses with a range of experience 
levels, with an objective to increase skills and confidence of less experienced nurses.  
Nurses reported collecting patient history often and with ease, while at the same time 
reporting a sub-optimal level of knowledge of which elements of a patient’s history are 
important to collect. These apparently incongruous findings may reveal an unperceived 
need for skills and knowledge in this area, as the frequency and ease of these tasks does not 
appear to accompany a thorough assessment. To concretize knowledge of which elements 
of patient history are significant, some settings use standardized tools
24
. However, current 
literature is divided on the use of such tools
25
. Gathering a detailed patient history is integral 
for the diagnosis of bleeding disorders
26
, especially inherited disorders, where symptoms 
may emerge periodically over the course of a patient’s life
27
.  A recent publication by the 
European Association for Haemophilia and Allied Disorders (EAHAD) favored the use of a 
standardized tool as a part of nursing practice
25
. Other groups have argued that the under-
use of such tools is detrimental to the quality of patient documentation
28
, or describe the 
problem as beyond simply using the tools. Rather, they highlight that education, cost and 
organizational changes are needed before beginning to use these tools, and thus are factors 
that undermine their practical utility
29
.   
Reports of challenges associated with specific patient profiles, specifically those with VWD 
and haemophilia patients with inhibitors, indicated two areas where nurses are in need of 
greater familiarity with risk factors, testing guidelines and diagnostic criteria.  Specifically, 
there is a need to keep abreast of the changing diagnostic criteria of VWD, and develop the 
communication skills required to manage patient treatment expectations. In addition, a 
greater knowledge of what is currently known and unknown regarding the prevention, 
treatment, and management of patients with inhibitors will improve the provision of patient 
education about these conditions, and is recommended as starting goals for future 
educational interventions. 
Nurses in this study were explicit about their need for educational offerings pertinent to 
their practice. In addition to a need for more learning materials aimed at nurses, situating 
learning activities within a clinical setting has been suggested as a way to increase 
competency, confidence, patient outcomes, and overall knowledge especially in newly-
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graduated nurses
30,31
. A perceived lack of support from senior staff when implementing 
learning into practice was mentioned by participants in this needs assessment. Aside from 
being unsure of where to access training, our study indicates that when nurses do receive 
training, there is a perception they do not have the support required to implement their 
training and knowledge. Top down support for education and mentorship is not adequate, 
despite facilitators in place, such as shared professional setting, and that multidisciplinary 
collaborations are recommended25,32.  
Bleeding and clotting disorders have significant effects on patients’ health and quality of 
life
33,34
. The ability for nurses to provide therapeutic care, including psychological support 
and education, is essential, especially given that these conditions are usually chronic, and 
that patient age and the severity of the disorder varies considerably. Therefore, the 
development of a variety of care competencies (in adherence with current treatment 
protocols) should be included in future education materials, with priority given to the 
challenges identified in this study. 
 
The sample size was appropriate for this type of exploratory mixed-methods study; 
however, given the study was conducted internationally, with total sample size distributed 
across several regions, differences between countries (reported in the tables, solely) should 
be interpreted only as indicators of the local educational needs of nurses in the field of 
thrombosis and haemostasis. 
Studies using self-reported participant data always carry risks to their accuracy, and 
purposive sampling methods may be at risk of selection bias. To account for these 
limitations, the researchers used data triangulation techniques that combined quantitative 
and qualitative data, a grounded knowledge base of expert faculty advisors, and a review of 
literature to strengthen and ensure the trustworthiness of the findings. 
Further research is needed to validate these findings when developing educational 
programs in countries not included in this study, and to further explore the applicability of 
this approach to other specialized areas of nursing.  
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This study offers a comprehensive illustration of the current challenges and barriers faced 
by nurses in the field of haemostasis and thrombosis, including main areas where skills or 
knowledge were reported to be sub-optimal in relation to clinical tasks and patient 
communication.  
In order to meet the needs of nurses in this field, educational programming must consider 
the broad range of nursing responsibilities as well as issues specific to clinical care for 
bleeding and clotting disorders. Nurse-specific educational resources are limited; therefore 
needs assessment studies are crucial when planning successful educational programs. 
Operationalizing evidence-based research can help overcome the identified challenges 
faced by nurses in this field, and reduce the deficit of educational resources identified by 
this cohort of nurses.   
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 NURSES  
N (%) 
PATIENTS / CAREGIVERS 
N (%) 
TOTAL 
N (%) 
PHASES  
PHASE 1 - Interviews 22 (10%) 22 (100%) 44 (19%) 
PHASE 2 – Online Survey 190 (90%) -- 190 (81%) 
COUNTRIES  
 23 (11%) 3 (14%) 26 (11%) 
FRANCE 22 (10%) 2 (9%) 24 (10%) 
SPAIN 23 (11%) 2 (9%) 25 (11%) 
GERMANY 23 (11%) 3 (14%) 26 (11%) 
CANADA 23 (11%) 2 (9%) 25 (11%) 
U.S 34 (16%) 4 (18%) 38 (16%) 
AUSTRALIA 19 (9%) 2 (9%) 21 (9%) 
CHINA 22 (10%) 2 (9%) 24 (10%) 
ARGENTINA 23 (11%) 2 (9%) 25 (11%) 
YEARS OF PRACTICE  
10 YEARS OF PRACTICE OR LESS 86 (41%) -- 86 (41%) 
11 YEARS OF PRACTICE OR MORE 126 (59%) -- 126 (59%) 
PRACTICE SETTING    
COMMUNITY SETTING 58 (27%) -- 58 (27%) 
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ACADEMIC SETTING OR SPECIALIZED CENTER 151 (71%) -- 151 (71%) 
OTHER 3 (1%) -- (1%) 
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KNOWLEDGE ITEMS % Of PARTICIPANTS 
THAT REPORTED SUB-
OPTIMAL KNOWLEDGE 
GAPS HIGHER 
AMONG*… 
GAPS LOWER AMONG*… STATISTICAL 
SIGNIFICANCE**  
ITEMS RELATED TO RISK ASSESSMENT  
Which eleŵeŶts of a patieŶt’s 
history are essential for the 
identification of a hereditary 
bleeding disorder, and to 
inform a diagnosis of 
hemophilia 
37% (62) NS NS NS 
Signs and symptoms of early 
and late hemarthrosis 
39% (64) NS NS NS 
Criteria to determine the 
severity level of hemophilia 
46% (76) 
UK (67%, 10) 
ARG (63%, 12) 
US (27%, 7), 
Spain (26%, 5) 
p = 0.037 
Conducting an assessment for 
menorrhagia 
32% (54) NS NS NS 
How to identify immune 
thrombocytopenia (ITP) 
42% (67) ≤ 10 YoP  (54%, 34)  10 YoP (38%, 33) p = 0.011 
Which elements of patients 
and family history to collect to 
43% (72) 
GER (74%, 14) 
CAN (63%, 12) 
FR (18%, 3) 
Spain (22%, 4) 
p = 0.005 A
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inform a potential diagnosis of 
VWD 
If the results of basic 
laboratory tests are consistent 
with VWD, and if so, which 
type 
50% (82) NS NS NS 
ITEMS RELATED TO VON WILLEBRAND DISEASE 
Criteria to identify the type of 
von Willebrand disease 
54% (87) 
ARG (75%, 12) 
CAN (72%, 13) 
China (22%, 4) 
Spain (32%, 6) 
p = 0.011 
Safety profile of treatments for 
von Willebrand disease 
52% (84) 
ARG (74%, 14) 
FR (67%, 10) 
China (22%, 4) 
Spain (29%, 5) 
p = 0.033 
≤ 10 YOP (62%, 42)  10 YOP (44%, 42) p = 0.027 
ITEMS RELATED TO ANTICOAGULATION 
Safety profile of 
anticoagulation medication in 
patients who have a history of 
bleeding episodes or bleeding 
disorders 
33% (60) 
AUS (56%,9) 
GER (58%, 11) 
 
U.S. (10%, 3) 
Spain (30%, 6) 
UK (30%, 6) 
p = 0.012 
Safety profile of 
anticoagulation medication in 
40% (75) 
FR (67%, 12) 
ARG (60%, 12) 
U.S. (13%, 4) 
China (25%, 5) 
p = 0.003 A
ut
ho
r M
an
us
cr
ip
t
 This article is protected by copyright. All rights reserved 
vulnerable patients 
Safety profile of direct oral 
anticoagulants (DOACs) in 
cancer patients 
48% (86) 
FR (69%, 11) 
ARG (68%, 13) 
U.S. (20%, 6) 
Spain (25%, 5) 
p = 0.001 
ITEMS RELATED TO INHIBITORS 
Safety profile of bypassing 
agent 
51% (82) ≤ 10 YOP (62%, 42)  10 YOP (43%, 40) p = 0.019 
Goals of inhibitor treatment 
and eradication 
52% (83) ≤ 10 YOP (63%, 42)  10 YOP (44%, 41) p = 0.02 
How to recognize potential 
inhibitor development 
53% (84) ≤ 10 YOP (68%, 45)  10 YOP (42%, 39) p = 0.001 
Inhibitor development risks for 
previously untreated patients 
52% (84) ≤ 10 YOP (65%, 42)  10 YOP (44%, 42) p = 0.009 
Question: For each of the following items, please rate your current knowledge level in your daily practice in relation to what they should be given your 
profession.  
Scale: 1=Low, 3=Acceptable, 5=Optimal, 6 = Not applicable to my practice. Data are the percentage of participants that selected 1, 2 or 3. 
*Only 2 countries with higher knowledge gaps are reported. 
** Only 2 countries with lower knowledge gaps are reported. 
*** Significant difference between countries or years of practice (10 years of practice or less vs. more than 10 years of practice) calculated using chi-square (p 
< .05).  Au
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